Blood Diseases Program

Full post available on Queens University of Charlotte blog. by Anna Pomaro, Queens University Communications;

By Anne Manning This article originally appeared in the Harvard Gazette. Many people couldn’t say where their thymus is, or what it does, and even doctors have long considered it expendable in adults. But new Harvard-led research suggests that the walnut...

By Alice McCarthy A recent paper published in New England Journal of Medicine reveals that treatment of myelodysplastic syndrome (MDS) with hypomethylating agents (HMAs) activates a sleeping oncogene, leading to poorer survival. This discovery raises the...

Fernando Camargo recognized for pioneering scientific contributions and outstanding leadership Fernando Camargo, Ph.D., has been named as the inaugural Regenerative Biology Endowed Chair by the Boston Children’s Hospital (BCH) Department of Pediatrics, in...

Novel delivery system for tissue-regenerative molecules enables local, sustained release for greater efficacy Alkem Laboratories Limited (Alkem) has signed a license agreement with Harvard University’s Office of Technology Development to develop and...

AWARD AMOUNT Up to $100,000 for entire project period Project period not to exceed 2 years POSTED DATE Monday, Nov 29, 2021 DEADLINE FOR APPLICATION Monday, February 7, 2022 ANTICIPATED AWARD DATE April 1, 2022 The Harvard Stem Cell Institute (HSCI) Blood...

HSCI researchers identify mechanism with therapeutic potential for anemia Each tissue in the body has different requirements for metabolism, or how it uses energy to function — for example, a muscle needs different molecules to fuel a contraction compared...

HSCI scientists find that signaling defects can influence red blood cell traits The field of genetics has made huge strides over the past couple of decades, from the first sequencing of the human genome to a growing understanding of the machinery that...

HSCI co-director David Scadden is part of a multi-institutional, cross-disciplinary team that has been awarded a $14.6 million grant from the National Institutes of Health. The team is using gene and cell therapy approaches to develop a potential cure for...

Harvard researchers target chemotherapy-resistant leukemia by using metabolism By Jessica Lau Blood cancers like leukemia can be effectively treated with chemotherapy, but relapse usually occurs, due to resistant cancer cells that evade the original drug...